Skip to main content

Accelerate Biopharma Drug Discovery with Genext Genomics

 The biopharmaceutical drug discovery process is a long and complex journey, but it has the potential to revolutionize human health. At Genext Genomics, we understand the challenges you face in bringing life-saving drugs to market faster. That's why we offer a comprehensive suite of services designed to streamline every stage of the biopharma drug discovery pipeline.

Our Expertise in Biopharma Drug Discovery Stages

As outlined in a recent article on the 5 Stages of Biopharma Drug Discovery, the biopharma drug discovery process can be broken down into five key stages:

Discovery and Development: This stage involves identifying potential drug candidates through target selection, hit identification, and lead optimization.

Preclinical Research: In this stage, promising drug candidates are tested in cell-based assays and animal models to assess their safety and efficacy.

Clinical Development: This stage involves conducting clinical trials on human volunteers to evaluate the drug's safety, efficacy, and dosage.

FDA Review: The FDA thoroughly reviews all submitted data to determine the drug's safety and effectiveness before granting marketing approval.

FDA Post-Market Safety Monitoring: Even after a drug is approved, the FDA continues to monitor its safety and effectiveness to ensure patient well-being.

Genext Genomics: Your Partner in Biopharma Drug Discovery Acceleration


Comments